Q2 2023 Holdings
Filed 2023-08-14 | 54 holdings | $5.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $1.0B | 11,225,357 | 18.9% |
| Legend Biotech Corp(LEGN) | COM | 52490G102 | $432.5M | 6,264,707 | 8.2% |
| Vaxcyte Inc(PCVX) | SPONSORED ADS | 92243G108 | $394.1M | 7,891,254 | 7.4% |
| Dice Therapeutics Inc | COM | 23345J104 | $365.0M | 7,856,612 | 6.9% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $216.4M | 11,416,948 | 4.1% |
| Biogen Inc(BIIB) | SPONSORED ADR | 09062X103 | $151.8M | 532,892 | 2.9% |
| Aerovate Therapeutics Inc | COM | 008064107 | $141.7M | 8,263,982 | 2.7% |
| Verona Pharma PLC(VRNA) | COM | 925050106 | $133.6M | 6,317,990 | 2.5% |
| Curevac N V | COM | N2451R105 | $127.6M | 12,245,955 | 2.4% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $123.2M | 7,236,454 | 2.3% |
| Newamsterdam Pharma Company(NAMS) | ORD SHS | N62509109 | $107.0M | 9,000,000 | 2.0% |
| Cytek Biosciences Inc(CTKB) | COM | 23285D109 | $105.0M | 12,297,721 | 2.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $102.9M | 8,670,644 | 1.9% |
| Geron Corp(GERN) | COM | 374163103 | $101.3M | 31,544,806 | 1.9% |
| Inhibrx Inc(INBXUSD) | SHS | 45720L107 | $100.0M | 3,853,867 | 1.9% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $93.6M | 5,676,067 | 1.8% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $93.2M | 7,809,852 | 1.8% |
| Rxsight Inc(RXST) | COM | 78349D107 | $87.9M | 3,052,796 | 1.7% |
| Cogent Communications Hldgs(COGT) | COM | 19240Q201 | $76.0M | 6,416,147 | 1.4% |
| Pepgen Inc(PEPG) | COM | 713317105 | $72.7M | 8,131,952 | 1.4% |
| Axsome Therapeutics Inc(AXSM) | CLASS A ORD SHS | 05464T104 | $71.9M | 1,000,000 | 1.4% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $71.2M | 6,416,998 | 1.3% |
| VOR Biopharma Inc | COM | 929033108 | $70.3M | 22,748,880 | 1.3% |
| GH Research PLC(GHRS) | SPONSORED ADR | G3855L106 | $66.3M | 5,587,333 | 1.3% |
| Wave Life Sciences LTD(WVE) | COM | Y95308105 | $62.6M | 17,202,009 | 1.2% |
| Acrivon Therapeutics Inc(ACRV) | COM | 004890109 | $62.3M | 4,810,508 | 1.2% |
| Icosavax Inc | COM | 45114M109 | $59.2M | 5,963,565 | 1.1% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $58.5M | 4,417,259 | 1.1% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $55.5M | 3,069,531 | 1.0% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $54.2M | 3,178,476 | 1.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $48.2M | 4,691,178 | 0.9% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $47.8M | 2,007,946 | 0.9% |
| Acumen Pharmaceuticals Inc(ABOS) | COMMON STOCK | 00509G209 | $47.0M | 9,770,773 | 0.9% |
| Aclaris Therapeutics Inc(ACRS) | SPONSORED ADS | 00461U105 | $45.6M | 4,398,453 | 0.9% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $44.0M | 2,329,958 | 0.8% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $43.3M | 2,122,465 | 0.8% |
| Fulcrum Therapeutics Inc(FULC) | CLASS A COM | 359616109 | $38.3M | 11,609,704 | 0.7% |
| Eliem Therapeutics Inc(CLYM) | ADS | 28658R106 | $36.8M | 13,150,849 | 0.7% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $35.6M | 6,067,483 | 0.7% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $32.1M | 3,773,517 | 0.6% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $31.9M | 1,762,000 | 0.6% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM | 30233G209 | $29.3M | 3,370,506 | 0.6% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $20.2M | 3,009,678 | 0.4% |
| Werewolf Therapeutics Inc(HOWL) | COM | 95075A107 | $18.7M | 6,144,881 | 0.4% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $18.7M | 2,971,231 | 0.4% |
| Solid Biosciences Inc(SLDB) | COM | 83422E204 | $18.0M | 3,426,286 | 0.3% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $17.8M | 3,525,754 | 0.3% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $17.1M | 7,805,129 | 0.3% |
| Celcuity Inc(CELC) | COM | 15102K100 | $15.4M | 1,400,001 | 0.3% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $8.7M | 937,500 | 0.2% |